EVENTS & PRESENTATIONS

PROMETRIKA is pleased to announce our participation in the IRT Conference 2025, to be held October 14–15, 2025, at The Westin Copley Place in Boston, MA.

The conference will convene experts in interactive response technologies, randomization, and clinical trial supply management to discuss best practices and explore new innovations in the field.

Kathy Zheng, Director of Project Management and Clinical Innovations, will represent PROMETRIKA at the event.

We look forward to conversations with colleagues and partners over these two days of learning.

Learn more about the conference here: https://informaconnect.com/interactive-response-technologies-in-clinical-trials/

PROMETRIKA is proud to be a Sponsor of the NERDs Workshop 2025 – New England Rare Disease Statistics, hosted by the New England Statistical Society.

Join us at the NERDs Workshop as we explore this year’s theme: “Shaping tomorrow: transforming rare disease drug development.”

NERDS 2025

At PROMETRIKA, our commitment to advancing rare disease research continues; sponsoring this event reflects our dedication to collaborating with scientists, statisticians, and regulators to push forward innovation and solutions.

PROMETRIKA is pleased to announce that we will be attending Fierce Biotech Week 2025, taking place October 7–9, 2025, at Encore Boston Harbor Hotel, MA.

This annual event gathers stakeholders from across the biotech and pharmaceutical industries, including clinical researchers, business development professionals, and regulatory experts.

Our team is looking forward to engaging with colleagues and partners throughout the event.

For more information about Fierce Biotech Week 2025, please visit https://www.fiercebiotechweek.com/

PROMETRIKA is pleased to announce that our data management team will be attending SCDM 2025.

SCDM is a flagship event for the clinical data management community, featuring workshops, panels, keynotes, and sessions that highlight innovations in data science, regulatory trends, AI/ML applications, and more.

Our team looks forward to engaging with peers, learning from industry leaders, and building connections across the clinical data and life sciences ecosystem.

For more information about SCDM 2025, visit: https://scdm.org/scdm-2025-annual-conference/

PROMETRIKA is proud to sponsor the 2025 Boston Taiwanese Biotechnology Association (BTBA) 13th Annual Symposium. This dynamic event brings together scientists, industry leaders, and young professionals to share ideas and explore the latest advances in biotechnology and biomedical research.

We look forward to connecting with attendees and celebrating innovation within this inspiring community. Learn more here.

PROMETRIKA is proud to present at PharmaSUG 2025, where our Statistical Programming team members will share their expertise:

Ning Ning, Statistical Programmer I, will present “Optimizing SAS Programming Pipelines Using the %Unpack and %SearchReplace Macros for Version Control and Customization”.

Click here to see our paper

Patrick Dowe,  Statistical Programmer III, and Gina Hird, Senior Statistical Programmer, will co-present “Automating Recurring Data Reconciliation for Serious Adverse Events Using SAS”.

Click here to see our paper 

Through these sessions, PROMETRIKA will contribute to advancing clinical trial data science and promoting quality, patient-focused research.

We’re pleased to announce that PROMETRIKA’s Susan Mutter, Director of Statistical Programming, will be presenting at the 2025 CDISC + TMF Europe Interchange in Geneva, Switzerland!

Her session, “Mapping REDCap Data into SDTM: A Case Study of Healthy Volunteer Research Data,” will provide insights into bridging the gap between academic research and CDISC standards. Susan will share lessons learned from mapping REDCap data to SDTM and discuss strategies for improving data standardization in research.

President & CEO, Miganush Stepanians, PhD, and Director of Clinical Operations and Pharmacovigilance, Chelsey Ryan, MSHS, PMP, will be attending the World Orphan Drug Congress USA 2025 this April.

The World Orphan Drug Congress brings together thought leaders, innovators, and professionals dedicated to improving the lives of patients with rare diseases. We look forward to engaging in meaningful discussions, sharing insights, and exploring new opportunities for collaboration to support the development of treatments for rare and underserved conditions.

Andrew Park, PharmD, PROMETRIKA’s Senior Medical Writer, will be hosting a roundtable on The Art of the Clinical Protocol QC at the American Medical Writers Association’s (AMWA) 2024 Medical Writing & Communication Conference. Protocols are known for being hotbeds for confusion and inconsistencies, especially in their initial form. Since they are often based on a previous and unrelated protocol, involve input from multiple internal and external teams, and need to incorporate increasingly complex study designs, it is not surprising that such issues arise. How can we ensure the final product accurately reflects the team’s intent? Andrew will explore and share common sources of inconsistencies, QC steps to identify them, and approaches to avoid inconsistency in the first place.

Miganush Stepanians, PhD, President and CEO, will be a Keynote Speaker at the 7th Annual New England Rare Disease Statistics (NERDS) Workshop 2024.

This year’s workshop theme is: Leaping Forward: Innovative Statistical Approaches in Rare Disease Drug Development. PROMETRIKA is pleased to join our statistics colleagues in the industry at this exciting event.